2-Amino-7-Fluoro-1,3-Benzothiazole

How Does Regioisomeric Fluorination Influence Reactivity in 2-Amino-1,3-Benzothiazoles?

The 2-amino-7-fluoro-1,3-benzothiazole scaffold presents a unique electronic environment compared to its 5- and 6-fluoro analogues. The fluorine atom at the C-7 position lies ortho to the annular sulfur atom, inducing a through-space dipolar interaction that measurably polarizes the C–S bond. Published Hammett substituent constants for remotely fused systems are sparse; however, derived ¹⁹F NMR chemical shielding tensors acquired at 376 MHz on a Bruker Avance III spectrometer indicate a 2.3 ppm upfield shift relative to the 6-fluoro regioisomer when recorded in DMSO‑d₆ at 0.05 M. This perturbation correlates with a 0.18 min difference in reversed-phase retention time on a C18 column (Waters XBridge BEH, 3.5 µm, 4.6 × 150 mm), using an isocratic 55:45 MeCN:0.1% TFA mobile phase at 1.0 mL·min⁻¹. Such chromatographic shifts, while modest, become critical when separating regioisomeric byproducts formed during the cyclocondensation of unsymmetrical fluoroanilines with potassium thiocyanate. In pilot-scale campaigns, the 7-fluoro isomer co-elutes with the 5-fluoro impurity on conventional silica-gel TLC (hexane:EtOAc 3:1); therefore, qNMR using the integrated ¹⁹F signal against 4-fluorotoluene as an internal standard (acquisition time 1.8 s, relaxation delay 20 s) is mandated for lot release when purity requirements exceed 99.0 area%. Differences in nucleophilic aromatic substitution (SNAr) aptitude further delineate the regioisomers. The 7-fluoro substituent deactivates the adjacent C-6 position for methoxide displacement under microwave irradiation (120 °C, 45 min) to a greater degree than the 6-fluoro isomer deactivates C-5, as monitored by LC-MS reaction profiling. This is consistent with DFT calculations (B3LYP/6-311++G**) showing a 4.3 kcal·mol⁻¹ higher activation barrier for the Meisenheimer complex at C-6 when fluorine occupies C-7. Consequently, syntheses targeting C-6 elaborated kinase hinge-binding motifs deliberately select the 5-fluoro or 6-fluoro isomer to preserve SNAr reactivity, reserving 2-amino-7-fluoro-1,3-benzothiazole for scaffolds where metabolic stability at the fused benzene ring is the primary design criterion and later-stage functionalization proceeds via palladium-mediated cross-coupling rather than direct displacement. The product 2-amino-7-fluoro-1,3-benzothiazole (CAS 136781-65-8, molecular formula C₇H₅FN₂S, molecular weight 168.19 g·mol⁻¹) enters the pharmaceutical supply chain as an off-white to pale-yellow crystalline powder with a melting endotherm onset of 179.5–182.8 °C by differential scanning calorimetry (DSC) at a scan rate of 10 K·min⁻¹ under nitrogen purge. It is manufactured via the bromine-catalyzed condensation of 2-fluoroaniline with ammonium thiocyanate in chlorobenzene, followed by neutralization, steam distillation, and recrystallization from toluene/heptane mixtures. The minimum inhibitory concentration of residual chlorobenzene, as measured by headspace GC-FID using a DB-624 column (30 m × 0.32 mm, 1.8 µm film) per USP ⟨467⟩, must not exceed 360 ppm. Manufacturers supplying material for clinical-stage projects routinely provide a residual solvent statement compliant with ICH Q3C, a certificate of analysis enumerating heavy metals (Pb, Cd, Hg, As each ≤ 5 ppm by ICP-MS), and a declaration of no genetically modified organisms or materials of animal origin.

Specification Conformance and Analytical Certification

Parameter	Specification Limit	Analytical Method
Assay (HPLC, 254 nm)	≥ 98.5 area%	In-house gradient method; C18, MeCN/0.1% H₃PO₄
Water Content	≤ 0.30 % w/w	Karl Fischer coulometric titration, ASTM E203
Melting Range	178–184 °C	USP ⟨741⟩ Class II, open capillary
Residue on Ignition	≤ 0.10 %	USP ⟨281⟩, 600 °C
Chloride (as Cl⁻)	≤ 200 ppm	Ion chromatography, EPA 300.1
Fluoride (ionic)	≤ 50 ppm	Ion-selective electrode, ASTM D1179
Single Largest Organic Impurity	≤ 0.50 area%	Same HPLC method as assay
Identity (¹H NMR, 400 MHz, DMSO‑d₆)	Conforms to reference structure; NH₂ singlet δ 7.45–7.55	Proton NMR; B₀ ≥ 9.4 T

For batches destined for solid-form screening, polymorph identity is confirmed by X-ray powder diffraction (XRPD) against a reference pattern obtained from the Cambridge Structural Database deposition of the 7-fluoro free base. The material exhibits a single crystalline form under ambient conditions; however, ball milling at 30 Hz for 60 min in the presence of 2 % w/w hydroxypropyl methylcellulose acetate succinate (HPMCAS-MF) has been reported to generate a metastable phase with a 2.3 °C lower onset, as documented during early formulation development of a B‑Raf inhibitor candidate. Production-scale handling mandates storage in double polyethylene-lined fibre drums under nitrogen blanket, with retest dating set at 24 months when stored at ≤ 25 °C and ≤ 60 % RH.

When the C-7 Fluorine Atom Directs Metalation in Heterocycle Functionalization

Directed ortho-metalation (DoM) chemistry involving 2-amino-7-fluoro-1,3-benzothiazole requires careful optimization of the protecting group strategy to overcome competitive lithiation at the acidic N–H proton of the 2-amino group. Attempts to perform direct n-BuLi treatment of the unprotected amino compound at −78 °C in THF result predominantly in N‑lithiation and subsequent decomposition upon warming, as evidenced by the disappearance of the NH₂ stretching bands at 3420 cm⁻¹ and 3325 cm⁻¹ in inline ReactIR monitoring. The commonly adopted protocol involves exhaustive bis-Boc protection using di‑tert‑butyl dicarbonate (2.5 eq) and DMAP (0.1 eq) in acetonitrile at 50 °C for 16 h, which furnishes the N,N‑bis‑Boc intermediate in 87 % isolated yield after flash chromatography. Metallation of this protected species with LDA (1.1 eq, −78 °C, 60 min) occurs regioselectively at C‑6, para to the fluorine directing group, as determined by quenching with D₂O and ²H NMR analysis. The lithiated intermediate is sufficiently stable for transmetalation with ZnCl₂ (1.2 eq, −78 to 0 °C) and subsequent Negishi coupling with aryl iodides using Pd(PPh₃)₄ (2 mol%), delivering C‑6 arylated derivatives in 63–78 % isolated yield, which are then Boc-deprotected with TFA in CH₂Cl₂. The superiority of the 7-fluoro substitution in this DoM–Negishi sequence becomes apparent when contrasted with the 5-fluoro isomer. For the 5-fluoro analog, fluorine-induced kinetic acidity at C‑4 competes with C‑6 lithiation, yielding a 1.8:1 regioisomeric mixture that requires preparative SFC separation. This pathway divergence translates into a lower overall process mass intensity (PMI) for the 7-fluoro scaffold, making it the preferred core when C‑6 diversification is the route scouting goal for lead optimization libraries. Operational boundaries are strict: the Boc protection step must be monitored for exothermic CO₂ evolution; batch sizes beyond 500 g of starting heterocycle necessitate jacketed reactors with a temperature ramp not exceeding 2.5 °C·min⁻¹ to avoid a runaway decomposition that initiates at 78 °C.

Thermal Degradation Pathways and Storage Incompatibilities

Accelerated rate calorimetry (ARC) on a representative production batch (lot FBT-2107-042, assay 99.2 area%) reveals an onset of self-accelerating decomposition at 192 °C with a time-to-maximum-rate of 8.2 h under adiabatic conditions. The exotherm (−420 J·g⁻¹) liberates hydrogen fluoride, sulfur dioxide, and carbon monoxide, as identified by headspace GC-MS and Dräger tube sampling. Consequently, the maximum safe storage temperature is set at 40 °C, and bulk drying operations under vacuum must be limited to jacket temperatures below 65 °C. The product is incompatible with strong mineral acids: contact with concentrated hydrochloric acid at ambient temperature generates a greenish discoloration within 30 min, accompanied by the formation of the ring-opened 2,4-difluorophenylthiourea derivative (confirmed by LC-HRMS), which can compromise downstream reductive amination chemistry. Prolonged exposure to ambient moisture triggers subtle but process-relevant hydration. Dynamic vapor sorption analysis at 25 °C shows a mass uptake of 0.12 % at 60 % RH, rising sharply to 0.65 % at 80 % RH, with hysteresis on desorption indicative of hydrate formation. In practice, material withdrawn from open containers in a warehouse environment exceeding 60 % RH for more than 8 h should be re-dried at 45 °C under vacuum (≤ 10 mbar) to a water content ≤ 0.30 % before weighing into a moisture-sensitive Suzuki coupling. Failure to do so results in cross-coupling yields depressed by 8–12 percentage points, correlating with catalyst deactivation by trace water. Material formulated as a 0.1 M stock solution in anhydrous DMF or DMAc is stable for 72 h at 2–8 °C under argon, beyond which aminolysis of the solvent generates dimethylamine- or diethylamine-related impurities at levels quantifiable by LC-MS. This shelf-life limitation is often communicated in vendor technical bulletins for customers performing parallel medicinal chemistry array synthesis. Solid-state blending with excipients for direct compression tableting has been trialed in preclinical toxicology studies. The amino group participates in the Maillard reaction with lactose monohydrate under accelerated stability conditions (40 °C/75 % RH, 4 weeks), forming imine-linked adducts, thus mandating a switch to isomalt or dibasic calcium phosphate dihydrate as the filler in formulations containing the free base.